PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Sliwa, Karen
TI  - Novel Biomarkers Aid in Diagnosis of PPCM
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 19--20
VI  - 14
IP  - 12
4099  - http://mdc.sagepub.com/content/14/12/19.short
4100  - http://mdc.sagepub.com/content/14/12/19.full
AB  - Peripartum cardiomyopathy (PPCM) is a potentially life-threatening disease that is manifest as heart failure with left ventricular systolic dysfunction that occurs toward the end of pregnancy or in the months following delivery. It is associated with significant mortality and morbidity. Although its etiology has recently been the subject of much study, PPCM remains a diagnosis of exclusion. This article discusses 2 potential biomarkers for PPCM that may improve diagnosis and thus treatment outcomes.